Candriam S.C.A. Roivant Sciences Ltd. Call Options Transaction History
Candriam S.C.A.
- $15.6 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
323Shares Held
494MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$708 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$666 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$495 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$439 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$387 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.58B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...